Wuhan Wuyao Pharmaceutical Co Ltd, a subsidiary of China Grand Enterprises and Grand Pharma (China) Co Ltd, is a distinguished manufacturer and distributor specialising in the production and marketing of pharmaceutical raw materials. The company excels in the manufacturing of over 40 active pharmaceutical ingredients (APIs) that adhere to GMP standards. Its manufacturing facilities have been thoroughly inspected and approved by authoritative bodies including the NMPA, USFDA, and EDQM. Positioned as a leading manufacturer, Wuhan Wuyao Pharmaceutical Co Ltd is renowned for its API products such as Metamizole Sodium, Metronidazole, Chloramphenicol, and a range of Adrenaline derivatives, with most products holding DMF and CEP certifications.

Services include:
- Anatomical Therapeutic Chemical (ATC) Classification
- Manufacturing and marketing of pharmaceutical raw materials
- Production of active pharmaceutical ingredients (APIs)
- Compliance with international quality standards (GMP, NMPA, USFDA, EDQM)
- Provision of DMF and CEP certifications for products

Wuhan Wuyao Pharmaceutical Co Ltd continues to uphold a commitment to quality and innovation within the pharmaceutical industry. For more information, please visit wyzy.cn.